Structural Heart Occluders

This channel includes news and new technology innovations about structural heart occluders. These include information of surgical repair and transcatheter closure of PFO, VSD, ASD and LAA. Devices include the Amplatzer and the Gore Helex

Amplatzer PFO Occluder, St. Jude Medical, Baylor Heart and Vascular Services, Fort Worth, Texas, first patients
News | Structural Heart Occluders | February 01, 2017
Amplatzer PFO Occluder Now Available at Baylor Heart and Vascular Services at Fort Worth
February 1, 2017 — Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to...
read more
NCDR, ACC, JACC, American College of Cardiology, national trends, heart disease treatments, trends in cardiovascular care
News | Cath Lab | January 23, 2017
New Report Highlights National Trends in Heart Disease Treatments
January 23, 2017 — Over 93 percent of heart attack patients are receiving stents within the guideline-recommended...
read more
watchman LAA occluder, LAAO registry
Feature | Left Atrial Appendage (LAA) Occluders | November 07, 2016
Positive Data for Watchman LAA Occluder Real-world Post-FDA Approval Experience
November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high...
read more
RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders | November 02, 2016
St. Jude Medical Announces Landmark Stroke Data from RESPECT Trial
November 2, 2016 — St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First...
read more
St. Jude Medical, Amplatzer PFO Occluder, FDA approval, U.S. launch
Technology | Structural Heart Occluders | November 02, 2016
St. Jude Medical Announces FDA Approval and U.S. Launch of Amplatzer PFO Occluder
November 2, 2016 — St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval and...
read more
St. Jude Medical, ADO II AS trial, congenital heart disease, PDA, Amplatzer Duct Occluder II AS
News | Congenital Heart | October 19, 2016
St. Jude Medical Announces New Clinical Trial to Treat Congenital Heart Defects
October 19, 2016 — St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II Additional...
read more
St. Jude Medical, Amplatzer Amulet LAA occluder, left atrial appendage, IDE trial
News | Left Atrial Appendage (LAA) Occluders | September 02, 2016
St. Jude Medical Launches Amplatzer Amulet LAA Occluder Trial
September 2, 2016 — St. Jude Medical Inc. announced the start of the St. Jude Medical Amplatzer Amulet IDE trial of the...
read more
PFO closure, patent foramen ovale, AAN recommendation, American Academy of Neurology, stroke patients
News | Structural Heart Occluders | August 08, 2016
AAN: PFO Closure Not Recommended for People with Heart Defect and Stroke
August 8, 2016 — Updated recommendations from the American Academy of Neurology (AAN) states that catheter-based...
read more
Watchman, left atrial appendage closure, LAA occluder

An illustration of a Watchman transcatheter LAA occluder being implanted.

Feature | Left Atrial Appendage (LAA) Occluders | August 01, 2016 | Dave Fornell
Update for LAA Occluder Technology News and Trends
Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...
read more
Videos | Structural Heart Occluders | June 16, 2016
VIDEO: Demonstration of a Transcatheter PFO Occluder Implantation
This is an animation, supplied by Gore, demonstrated how the Cardioform Septal Occluder is implanted for the...
read more
PFO occluder, amplatzer
Feature | Structural Heart Occluders | May 27, 2016 | Dave Fornell
PFO Occluder for Cryptogenic Stroke Recommended by FDA Panel
May 27, 2016 — A U.S. Food and Drug Administration (FDA) panel recommended approval of a transcatheter patent foramen...
read more
Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman

The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.

Feature | Left Atrial Appendage (LAA) Occluders | May 20, 2016 | Dave Fornell
Occluding the Left Atrial Appendage (LAA)
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk...
read more
Videos | Left Atrial Appendage (LAA) Occluders | April 15, 2016
Post-FDA Approval Experience of LAA Occluders at ACC.16
David Holmes, M.D., professor of medicine, Mayo Clinic College of Medicine and consultant, Department of Internal...
read more
Watchman, left atrial appendage closure, LAA occluder
Technology | Left Atrial Appendage (LAA) Occluders | February 09, 2016
Medicare Will Cover Watchman Left Atrial Appendage Closure Device
February 9, 2016 — Boston Scientific Corp. announced the Centers for Medicare and Medicaid Services (CMS) will cover...
read more
transcatheter repair of a mitral valve paravalvular leak. Transcatheter repair of a surgical mitral replacement paravalvular leak with an Amplatzer Vascular Plug II.

Transcatheter repair of a surgical mitral replacement paravalvular leak with an Amplatzer Vascular Plug II.

Feature | Heart Valve Technology | February 08, 2016 | Dave Fornell
Transcatheter Repair of Paravalvular Leak
Off-label use of the St. Jude Amplatzer vascular plug devices offers a new solution for the minimally invasive repair...
read more
© Copyright Wainscot Media. All Rights Reserved.